Corrigendum: A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

1. Targeting GLUTs in Cancer: Mechanisms, Combination Strategies, and Translational Challenges.Current medical science · 2026
   Review
2. Integrated application of transcriptomics and metabolomics provides insights into acute hepatopancreatic necrosis disease resistance of Pacific white shrimpmSystems · 2023
   Article
3. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis.Nature medicine · 2021
   Article
4. Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma.Journal of cancer research and clinical oncology · 2020
   Article
5. Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation.Cell metabolism · 2019
   Article

Corrections and comments

• Erratum for
  A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.2016

Authors and funding

32 authors.

Funding

Abstract

PubMed holds no abstract for this paper.